TESS BARNES: Open Payments
NPI 1457705154 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 29 payments from 15 companies in 2025. Trend: 2023 $317 · 2024 $266 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| GlaxoSmithKline, LLC. | 5 | $90 |
| Lilly USA, LLC | 3 | $55 |
| Abbott Laboratories | 2 | $49 |
| ABBVIE INC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, OCTRODE, CREON, Ozempic, RECORLEV, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
